NCT02874820 - I2PETPG - Imidazoline2 Binding Sites in a Group of Participants Diagnosed With AD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

July 31, 2017

Conditions

Alzheimer Disease

Interventions

RADIATION

[11C]BU99008

Baseline and blocked scans

DRUG

Idazoxan

Idazoxan dose up to 80mg

Trial Locations (1)

W12 0NN

Centre for Neuropsychopharmacology; Division of Brain Sciences; Imperial College London; Burlington Danes Building; Hammersmith Hospital campus; 160 Du Cane Road, London